文献速递骨质疏松与代谢性骨病

为痴呆老年人停用双膦酸盐:照护者的观点

Deprescribing bisphosphonates for older adults with dementia: perspectives of caregivers.
PubMed 文献 · Osteoporos Int · 2023-11-18

该定性研究访谈了11名痴呆老年人的家庭或非正式照护者,探讨其对继续或停用双膦酸盐的决策因素。照护者认为骨折预防对维持功能独立重要,但护理目标变化时停用合理;以「最在意什么」为基础的沟通可能优化治疗。

要点

  • 照护者认为骨折预防对维持功能独立重要,但接近生命终末期时可能变得不那么重要。
  • 双膦酸盐总体耐受良好,但胃肠道不良反应、偏好更少治疗及痴呆相关行为可能成为停药原因。
  • 以照护者经历和「最在意什么」为基础的沟通可能有助于优化骨折预防治疗。

核心结论

  • 以照护者经历和「最在意什么」为基础的沟通可能有助于优化痴呆老年人的骨折预防治疗。

研究设计与样本

  • 对11名社区或长期护理机构中接受双膦酸盐治疗的痴呆老年人的家庭或非正式照护者进行访谈。
  • 采用以健康信念模型为指导的定性框架方法学进行分析。

主要发现

  • 多数照护者为男性(n=8)、年龄小于65岁(n=8)且为成年子女照护者(n=8)。
  • 3名照护者为黑人,5名为拉丁裔。
  • 许多照护者认为骨折预防治疗重要,但数名指出在接近生命终末期时可能变得不那么重要。
  • 照护者认为骨折预防治疗的感知益处包括改善生活质量和维持独立。
  • 多数照护者表示双膦酸盐耐受良好,但胃肠道不良反应、偏好更少治疗及痴呆相关行为可能成为停药原因。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Little is known about caregivers' perspectives on deprescribing bisphosphonates for older adults with dementia. Caregivers agreed that fracture prevention was important for maintaining functional independence but acknowledged that changing goals of care may justify deprescribing. Conversations grounded in "what matters most" can align fracture prevention treatment with goals of care. PURPOSE: The long-term fracture prevention benefits of bisphosphonates may begin to be overshadowed by the potential burden of adverse effects and polypharmacy for older adults living with dementia as the disease progresses. We characterized factors that influence caregiver decision-making for continuing versus deprescribing bisphosphonates for persons living with dementia. METHODS: We conducted 11 interviews with family or informal caregivers of older adults living with dementia in the community or in long-term care who had been treated with bisphosphonates. Interviews focused on experiences caring for someone who has experienced a fracture, perceived benefits and harms of bisphosphonates, and experiences with deprescribing. Analyses were conducted using a qualitative framework methodology guided by the Health Belief Model. RESULTS: Most caregivers were male (n = 8), younger than 65 (n = 8) and were an adult child caregiver (n = 8). Three caregivers were Black and five were Latino/a. Attempts to maintain functional independence despite high likelihood of falls was frequently discussed as contributing to fracture risk, in this population. Many caregivers perceived fracture prevention treatment as important, while several noted that it may become less important near the end of life. Perceived benefits of fracture prevention treatment for persons with dementia included improved quality of life and maintaining independence. Although most indicated that bisphosphonates were well tolerated, gastrointestinal adverse effects, preference for fewer treatments, and dementia-related behaviors that interfere with medication administration may be reasons for deprescribing. CONCLUSION: Conversations grounded in caregiver experiences and "what matters most" may help optimize fracture prevention treatment for older adults with dementia.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Niznik JD, Kelley CJ, Fasth L, et al. Deprescribing bisphosphonates for older adults with dementia: perspectives of caregivers. Osteoporos Int. 2023. PMID: 37980284. doi:10.1007/s00198-023-06967-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。